Werewolf Therapeutics Announces Pricing of Upsized Initial Public Offering
April 29, 2021 21:19 ET
|
Werewolf Therapeutics, Inc.
CAMBRIDGE, Mass., April 29, 2021 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (NASDAQ: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated...